Avecho turns to new investors to raise funds for CBD clinical trial by Steve Jones May 9, 2023April 30, 2024 Over-the-counter CBD hopeful Avecho Biotechnology will turn its focus on generating capital from new investors after […]
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Emyria strikes commercial deal with Aspen for over-the-counter product by Steve Jones April 4, 2023April 30, 2024
Ecofibre becomes second company to confirm disappointing sleep trial results by Steve Jones January 30, 2023March 13, 2023
Sleepless nights ahead for Cann Group as over-the-counter CBD trial fails the placebo challenge by Steve Jones January 19, 2023January 19, 2023
Cann Group poised to scale-up production after securing A$8.2m from shareholders by Steve Jones December 5, 2022April 29, 2024
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Wellnex warns of ‘limited shelf space’ as firm lays groundwork for OTC launch by Steve Jones October 6, 2022April 29, 2024